Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
Hiroaki Yokomori(Kitasato University Medical Center), Toshifumi Hibi∥(Kitasato Institute Hospital), Masaya Oda(Tokyo Metropolitan Neurological Hospital), Yuko Kitagawa(Keio University), Shigeyuki Kawachi(Keio University), Minoru Tanabe(Tokyo Institute of Technology), Kazunori Yoshimura(Nihon Institute of Medical Science), Fumihiko Kaneko(Kitasato University Medical Center)
Cited by 38
Related Papers
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
|Gastroenterology|2013|938
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267